26
Views
31
CrossRef citations to date
0
Altmetric
Original Article

CHOP Versus Chlorambucil + Prednisolone in Chronic Lymphocytic Leukemia

, , , , , , & show all
Pages 97-100 | Published online: 01 Jul 2009

References

  • French Cooperative Group on Chronic Lymphocytic Leukaemia. Effectiveness of “CHOP” regimen in advanced untreated chronic lymphocytic leukaemia. Lancet 1986; II: 1346–49
  • Montserrat E., Alcalá A., Alonso C., Besalduch J., Moraleda J. M., García-Conde J., Gutierrez M., Gomis F., Garijo J., Guzmán M. C., Estapé J., Rozman C. A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C. Nouv. Ren. Fr. Hematol. 1988; 30: 429–32
  • Jaksic B., Brugiatelli M. High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL: IGCI CLL-01 trial. Nouv. Rev. Fr. Hematol. 1988; 30: 437–42
  • Bennett J. M., Raphael B., Moore D., Silber R., Oken M. M., Rubin P. Comparison of chlorambucil and prednisone vs total body irradiation and chlorambucil/prednisone vs cytoxan, vincristine, prednisone for the therapy of active chronic lymphocytic leukemia: a long term follow-up of two ECOG studies. Chronic Lymphocytic Leukemia: recent progress and future direction. UCLA Symposium on Molecular and Cellular Biology, New Series, R. P. Gale, K. R. Rai. Alan Liss, New York 1987; Vol. 59: 317–27
  • Catovsky D., Fooks J., Richards S. The UK Medical Research Council CLL trials 1 and 2. Nouv. Rev. Fr. Hematol. 1988; 30: 423–27
  • Kimby E., Mellstedt H. Chlorambucil/Prednisolone versus CHOP in symptomatic chronic lymphocytic leukemia of B-cell type. 5th international workshop on CLL. 1991, (Abstract)
  • Geisler C., Mørk Hansen M. chronic lymphocytic leukaemia: A test of a proposed new clinical staging system. Scand. J. Haematol. 1981; 27: 279–86

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.